News

In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing ...
Highlights society guidelines recommending non-endoscopic biomarker testing, such as Lucid's EsoGuard Esophageal DNA Test, as an acceptable alternative to endoscopy "This update is an important ...
About Lucid DiagnosticsLucid Diagnostics Inc. is a commercial-stage, cancer prevention ... national-comprehensive-cancer-network-nccn-guidelines-now-include-esophageal-precancer-screening ...
Highlights society guidelines recommending non-endoscopic biomarker testing, such as Lucid's EsoGuard Esophageal DNA Test, as an acceptable alternative to endoscopy Lucid Diagnostics Inc., markets the ...